Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
The index swap takes effect October 9 and will force passive funds tracking the Nasdaq-100 to buy Moderna shares and sell Warner Bros. Discovery.
Moderna will replace Warner Bros. Discovery in the Nasdaq-100 index on October 9, triggering mechanical buying and selling from index-tracking funds.
A U.S. judge's approval lets Paramount close its acquisition of Warner Bros Discovery just as WBD shares touched $30.93.
A U.S. judge allowed Paramount to close its purchase of Warner Bros Discovery, and WBD stock hit a 52-week high of $30.93 in response.
Paramount's debt sale to fund its Warner Bros purchase became the latest test of how much borrowing the market can absorb at today's rates.
Yields on U.S. government debt have risen so fast in recent months that traders are calling it one of the sharpest jumps in a generation, and corporate borrowers are already feeling the squeeze.
Both media companies rallied on reports that antitrust settlement discussions are advancing, while Netflix shares did not move with them.
Warner Bros. Discovery rose 7% and Paramount Skydance climbed 5% in the September 21 session after reports said talks to settle antitrust concerns over their proposed tie-up are progressing.
The Wall Street Journal reports advanced talks come as Paramount separately discusses CNN oversight and film-release commitments with state officials.
Paramount is in advanced talks to settle a lawsuit tied to its Warner Bros. Discovery deal, according to the Wall Street Journal, while also negotiating with states over CNN monitoring and film-release commitments.
A cluster of insider sales spanning Illumina, Krystal Biotech, CrowdStrike, Warner Bros. Discovery and NMI Holdings raises the question of whether executives see limited upside from here.
Illumina director Keith Meister sold $57.2 million in stock, the largest of at least seven insider sales disclosed in the period, together totaling well over $80 million across unrelated sectors.
More than a dozen Form 4 disclosures in 24 hours — led by Thermo Fisher CEO Marc Casper's $8.6m disposal and Magnite's $660k of combined executive sales — point to a broad monetisation impulse at elevated equity valuations.
A dense cluster of insider disposals spanning Thermo Fisher, Block, Magnite, Colgate-Palmolive, IFF, Aurora Innovation, Tenet Healthcare, Accel Entertainment, Cohen & Co, Gevo and Warner Bros. Discovery signals executives are trimming exposure after a powerful equity run. While individually routine, the aggregate pattern is a classic late-cycle tell.
Zaslav's $27.1 million Warner Bros. Discovery disposal headlines a cluster of executive and director sales spanning Natera, Morningstar, CoreCivic and AeroVironment
A wide cross-section of insiders reduced holdings in the latest filing batch, led by Warner Bros. Discovery CEO David Zaslav's $27.1 million sale, alongside disposals at Natera, Morningstar, CoreCivic, California Water Service and AeroVironment.
President's $16 million disposal and director Kenneth Lowe's $3.2 million sale headline a broad cluster of executive selling across media, space and health-tech names, with buying activity conspicuously scarce.
A concentrated wave of Form 4 filings shows senior Warner Bros. Discovery executives cashing out roughly $19 million in stock, part of a wider 24-hour insider-selling cluster spanning Intuitive Machines, BillionToOne, Townsquare Media and California Resources. The lone material insider purchase came from a Via Transportation director.